The impact of circulating nucleosomes on inflammation in acute lung injury
- Saugata Dutta,
- Yin Zhu,
- Sultan Almuntashiri,
- Payaningal R. Somanath,
- ,
- Charlie Norwood VA Medical Center,
- ,
- Augusta University,
- Instituto Nacional de Enfermedades Respiratorias,
- Instituto Tecnologico de Estudios Superiores de Monterrey,
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOpen access
Abstract
<p>Extracellular histones are released in two major forms: free histones and nucleosomes (DNA-bound histones). However, little distinction has been made between these two forms of circulating extracellular histones. Our study detected increased circulating nucleosomes in acute lung injury patients. Further, our group identified nucleosomes as the leading form of extracellular histones compared to free histones in the plasma of COVID-19 patients, underscoring the necessity to reassess the forms of circulating histones and nucleosome contributions to immunopathology. Functionally, nucleosomes activated macrophages and induced inflammation in different organs. Mechanistically, we observed nucleosomes activating the NF-κB signaling, while inhibition of NF-κB by sulfasalazine attenuated nucleosome-induced macrophage activation. Taken together, our study indicates that extracellular histones are predominantly released as nucleosomes, playing a critical role in the inflammation of the lungs and other organs.</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
English (US)Article number
e70214Journal (Volume, Issue Number)
FASEB Journal (Volume 38, Issue 23)Publication milestones
- Published - 12/2024
Publication status
Published - 12/2024
ISSN
0892-6638Publication IDs
- Scopus: 85211132315
- PubMed: 39612188
Publication metrics
Metrics
Fractional count
2
Fractional count
0.13
Fractional count
14
Fractional count
0.88
Fractional count
2
Fractional count
1
PlumX, opens in new tab
Mentions
1
Citation count
5
Captures
3
Funding Details
We thank the National Heart, Lung, and Blood Institute's Biological Specimen and Data Repository Information Coordinating Center and the Fluid and Catheter Treatment Trial team. We thank Drs. Andrea Sikora and Aaron M. Chase at the University of Georgia College of Pharmacy and Mr. Sauradeep Dutta at the Southern University Bangladesh for editing and constructive feedback. The graphical abstract was created with BioRender.com. This work was supported by National Heart, Lung, and Blood Institute (NHLBI) grant R00HL141685 and R56HL163607 to DZ; National Institute of Allergy and Infectious Diseases (NIAID) grant R03 AI169063 and NIH-funded Georgia CTSA KL2 and UL1 grants (KL2TR002381 and UL1TR002378) to XW. The funding bodies were not involved in the design of the study, the collection, analysis, and interpretation of data, or in the writing of the manuscript.
We thank the National Heart, Lung, and Blood Institute's Biological Specimen and Data Repository Information Coordinating Center and the Fluid and Catheter Treatment Trial team. We thank Drs. Andrea Sikora and Aaron M. Chase at the University of Georgia College of Pharmacy and Mr. Sauradeep Dutta at the Southern University Bangladesh for editing and constructive feedback. The graphical abstract was created with BioRender.com. This work was supported by National Heart, Lung, and Blood Institute (NHLBI) grant R00HL141685 and R56HL163607 to DZ; National Institute of Allergy and Infectious Diseases (NIAID) grant R03 AI169063 and NIH‐funded Georgia CTSA KL2 and UL1 grants (KL2TR002381 and UL1TR002378) to XW. The funding bodies were not involved in the design of the study, the collection, analysis, and interpretation of data, or in the writing of the manuscript.
FundersFunding numbers
Fluid and Catheter Treatment Trial team
-NIH-funded Georgia
-Southern University
-NIH-funded Georgia
CTSA KL2, UL1TR002378, KL2TR002381
NIAID
R03 AI169063
NHLBI
R00HL141685, R56HL163607
